Abstract:Lower extremity deep vein thrombosis (DVT) is a common peripheral vascular disease, in which inflammation plays an important role. The aim of the present study was to investigate the expression and role of inflammatory factors in DVT. A rat model of venous thrombosis of the lower extremities was established through venous ligation surgery. The rats were examined at 2, 8, 24, 48 and 72 h after the induction of inferior venous stenosis and compared with control and sham surgery groups. The serum levels of interleukin-1β (IL-1β), tissue factor (TF) and xanthine oxidase (XOD) were measured using ELISAs. The morphology of the DVT tissue was observed by hematoxylin and eosin staining. Circulating endothelial cells (CECs) in peripheral blood were counted by flow cytometry. Reverse transcription-quantitative PCR and western blotting were used to detect mRNA and protein expression, respectively. The serum levels of IL-1β, TF and XOD exhibited no significant differences between the control and sham surgery groups. However, those in the rat model of DVT presented an upward trend from 2 to 24 h and peaked at 24 h, with a significant difference from the respective levels in the control and sham surgery groups. The histopathological analysis revealed the presence of red and mixed thrombi in the rats 2-48 h following the induction of inferior venous stenosis group with inflammatory cell infiltration in the vascular wall. Thrombus formation was evident after 72 h. While significant difference was observed in the number of CECs in the peripheral blood between the control and sham surgery groups, the number of peripheral blood CECs in the rats with inferior venous stenosis group increased from 8 to 72 h, with significant differences among these groups. The mRNA levels of IL-1β, TF, XOD and NF-κB in the tissues peaked at 24 h, with significant differences compared with those in the control and sham surgery groups. In addition, the protein expression level of NF-κB increased from 2 to 72 h. In conclusion, these results suggest that the high expression of IL-1β, TF, XOD and NF-κB may promote thrombus formation.

Inflammation Modulates Murine Venous Thrombosis Resolution in Vivo

Inflammation Modulates Murine Venous Thrombosis Resolution in Vivo: Assessment by Multimodal Fluorescence Molecular Imaging.

Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model

A vein wall cell atlas of murine venous thrombosis determined by single-cell RNA sequencing

Pro-inflammatory Chemokine Interleukin-17A May Increase Venous Thrombus Resolution by Increasing Venous Thrombus Neovascularization

Molecular Detection of Venous Thrombosis in Mouse Models Using SPECT/CT

Regulation of macrophage fibrinolysis during venous thrombus resolution

Expression and Role of Interleukin‑1β and Associated Biomarkers in Deep Vein Thrombosis

In Vivo Monitoring of Thrombosis in Mice by Optical Coherence Tomography.

Intravital Imaging of Thrombosis Models in Mice

A Quantitative Method for the Evaluation of Deep Vein Thrombosis in a Murine Model Using Three-Dimensional Ultrasound Imaging

Targeted microbubbles combined with low-power focused ultrasound promote the thrombolysis of acute deep vein thrombosis

In Vivo Near-Infrared Imaging Of Fibrin Deposition In Thromboembolic Stroke In Mice

Intravenous Release of NO from Lipidic Microbubbles Accelerates Deep Vein Thrombosis Resolution in a Rat Model

Thrombolysis of Deep Vein Thrombosis and Inhibiting Chemotaxis of Macrophage by Mcp-1 Blockage

The time-dependent expression of FPR2 and ANXA1 in murine deep vein thrombosis model and its relation to thrombus age

Resveratrol Ameliorates Deep Vein Thrombosis-Induced Inflammatory Response Through Inhibiting HIF-1α/NLRP3 Pathway

Two-photon intravital imaging of thrombus development.

Monocyte/macrophage-mediated venous thrombus resolution

Abstract 554: Monocyte Toll-like Receptor 4 (tlr4) Signaling Is Essential For Post Thrombotic Upa Expression

Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism